Poseida Therapeutics Newsroom

BTIG Maintains Poseida Therapeutics(PSTX.US) With Hold Rating

Moomoo NewsDec 10 07:31 ET

Cautious Hold Rating on Poseida Therapeutics Amid Promising Data and Strategic Uncertainties

TipRanksDec 10 07:11 ET

Piper Sandler Maintains Poseida Therapeutics(PSTX.US) With Hold Rating, Maintains Target Price $10

Moomoo NewsDec 2 07:32 ET

Piper Sandler Downgrades Poseida Therapeutics(PSTX.US) to Hold Rating, Maintains Target Price $10

Moomoo NewsDec 2 05:34 ET

A Quick Look at Today's Ratings for Poseida Therapeutics(PSTX.US), With a Forecast Between $9 to $9

Moomoo NewsNov 27 08:03 ET

Poseida Therapeutics Cut to Market Perform From Outperform by William Blair

Dow JonesNov 26 11:24 ET

Poseida Therapeutics Analyst Ratings

BenzingaNov 26 09:14 ET

Cantor Fitzgerald Downgrades Poseida Therapeutics(PSTX.US) to Hold Rating

Moomoo NewsNov 26 07:36 ET

BTIG Downgrades Poseida Therapeutics(PSTX.US) to Hold Rating

Moomoo NewsNov 26 07:34 ET

Poseida Therapeutics (PSTX) Was Downgraded to a Hold Rating at BTIG

TipRanksNov 26 07:11 ET

Piper Sandler Maintains Poseida Therapeutics(PSTX.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 15 07:31 ET

Poseida Therapeutics Analyst Ratings

BenzingaNov 15 07:22 ET

Poseida Therapeutics (PSTX) Receives a Buy From Piper Sandler

TipRanksNov 15 07:13 ET

H.C. Wainwright Maintains Poseida Therapeutics(PSTX.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsNov 15 06:31 ET

William Blair Maintains Poseida Therapeutics(PSTX.US) With Buy Rating

Moomoo NewsNov 15 03:32 ET

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Poseida Therapeutics (PSTX) and Evolus (EOLS)

TipRanksNov 8 07:32 ET

H.C. Wainwright Maintains Poseida Therapeutics(PSTX.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsNov 8 07:31 ET

William Blair Maintains Poseida Therapeutics(PSTX.US) With Buy Rating

Moomoo NewsNov 8 07:31 ET

Poseida Therapeutics' Robust Financial Performance and Strategic Collaborations Justify Buy Rating

TipRanksNov 8 07:02 ET

H.C. Wainwright Maintains Poseida Therapeutics(PSTX.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsOct 30 06:35 ET